For the first time, researchers here have detected and measured the soluble protein aggregates associated with the progression of Alzheimer’s disease in the spinal fluid of patients with both early-stage and advanced forms of the disease.

A departmental start-up has been chosen as a semi-finalist in the Cambridge Enterprise Postdoc Business Competition. Pept2Smart is aiming to provide researchers with the tools to create new types of drugs to treat diseases that other drugs cannot.

Josie Gaynord is a PhD candidate in the Department of Chemistry under the supervision of Professor David Spring. Her research looks at one of the biggest problems threatening global public health: antimicrobial resistance, or AMR. 

Professor Matthew Gaunt, an outstanding synthetic chemist whose work has been recognised by a series of prestigious awards, has been elected the 16th holder of the Yusuf Hamied 1702 Chair of Chemistry at the University of Cambridge.

We'll be welcoming prospective undergraduates during the University Open Days on Thursday and Friday. They are coming to find out what it's like to study here, and we'll be offering them a sample lecture.

Research co-led by this department has identified the mechanism behind the hardening of the arteries - and shown in animal studies that an antibiotic widely prescribed for acne could be an effective treatment.

Researchers here studying the way Nature manages and manipulates light argue in the journal Nature Photonics that cellulose is an ideal candidate for the development of more renewable and biodegradable photonic materials.

Congratulations to our colleague Professor Jason Chin and his team who, in creating an artificial version of E. coli with synthetic DNA, have paved the way for designer bacteria that could manufacture new materials, drugs and proteins. 

Six researchers from this department have received prestigious Royal Society of Chemistry prizes. Their work spans the molecular origins of neurodegenerative diseases, synthetic organic chemistry and electrochemical devices.

A study by researchers here that was published in the wake of two high-profile Alzheimer’s drug trial failures offers evidence for taking a wider approach to treating the disease.

An article co-written by a Professor in this department argues that unconscious bias in academic publishing disadvantages women.

Congratulations to department alumnus Dr Yusuf K Hamied, who has been elected an Honorary Fellow of the Royal Society.

A young researcher studying protein-misfolding in neurodegenerative diseases has been elected to the 2019 Schmidt Science Fellows programme. This aims to develop future science leaders who can address the world's most significant problems.

A young researcher in the Klenerman group has received a prestigious award from Alzheimer’s Research UK for his dementia research.

For her work in developing longer lasting, higher energy density and cheaper rechargeable batteries, our colleague Professor Clare Grey has won an Advanced Grant from the European Research Council (ERC).